Article in Toxins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Miklós PoórDepartment of Laboratory Medicine, Medical School, University of Pécs, Ifjúság útja 13, H-7624 Pécs, Hungary.ORCID 0000-0003-1425-7459
Patrik GömbösInstitute of Physiology and Nutrition, Department of Physiology and Animal Health, Agribiotechnology and Precision Breeding for Food Security National Laboratory, Hungarian University of Agriculture and Life Sciences, H-2103 Gödöllő, Hungary.
András SzabóInstitute of Physiology and Nutrition, Department of Physiology and Animal Health, Agribiotechnology and Precision Breeding for Food Security National Laboratory, Hungarian University of Agriculture and Life Sciences, H-2103 Gödöllő, Hungary.ORCID 0000-0002-5315-0024
Balázs Zoltán ZsidóPharmacoinformatics Unit, Department of Pharmacology and Pharmacotherapy, Medical School, University of Pécs, Szigeti út 12, H-7624 Pécs, Hungary.
Csaba HetényiPharmacoinformatics Unit, Department of Pharmacology and Pharmacotherapy, Medical School, University of Pécs, Szigeti út 12, H-7624 Pécs, Hungary.ORCID 0000-0002-8013-971X
Tamás HuberDepartment of Biophysics, Medical School, University of Pécs, Szigeti út 12, H-7624 Pécs, Hungary.
András LukácsDepartment of Biophysics, Medical School, University of Pécs, Szigeti út 12, H-7624 Pécs, Hungary.
Sándor Kunsági-MátéDepartment of Organic and Medicinal Chemistry, Faculty of Pharmacy, University of Pécs, Honvéd u. 1, H-7624 Pécs, Hungary.ORCID 0000-0002-1554-4225
Funding
Hungarian Academy of Sciences HUN-REN-MATEHungarian National Laboratory project RRF-2.3.1-21-2022-00007Ministry of Culture and Innovation of Hungary TKP2021-EGA-17National Research, Development and Innovation Office FK138184National Research, Development and Innovation Office RRF-2.3.1-21-2022-00015
6 · The paper itself
Abstract
Mycotoxins are frequent food contaminants posing health risk to humans and animals. Since these interactions have been barely studied yet, we examined the potential complex formation of mycotoxins with human α
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Interaction of Mycotoxins with α · full record | Socratic